# Phase I Study of Topical CRx-191 in Normal Healthy Volunteers

> **NCT00544687** · PHASE1 · COMPLETED · sponsor: **Zalicus** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** CRx-191
- **DRUG:** mometasone furoate
- **DRUG:** nortriptyline HCl
- **DRUG:** Karison® Creme
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT00544687
- **Lead sponsor:** Zalicus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2007-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00544687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00544687, "Phase I Study of Topical CRx-191 in Normal Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00544687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*